Bor-Sheng Ko

Title: Bor-Sheng Ko: Innovator in Hematological Technologies

Introduction

Bor-Sheng Ko is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical technology, particularly in the area of hematology. With a total of 2 patents, his work focuses on improving prognosis prediction and automated detection of hematological abnormalities.

Latest Patents

Ko's latest patents include "Systems and methods for prognosis prediction of acute myeloid leukemia patients." This application describes a computer-implemented method that processes medical record data to provide prognosis outcomes using a trained neural network. The method involves receiving patient data, processing time-dependent progression attributes, and combining them with static variables to generate multiple vectors for classification.

Another notable patent is "Systems and methods for automated hematological abnormality detection." This application outlines an automated system designed to identify hematological abnormalities through flow cytometry data. The system converts flow cytometry data into high-dimensional vectors and trains a classifier based on a comprehensive training dataset.

Career Highlights

Bor-Sheng Ko is affiliated with National Taiwan University, where he continues to advance research in medical technologies. His innovative approaches have the potential to significantly impact patient care and diagnosis in hematology.

Collaborations

Ko collaborates with esteemed colleagues such as Chi-Chun Lee and Jeng-Lin Li, contributing to a dynamic research environment focused on hematological advancements.

Conclusion

Bor-Sheng Ko's work exemplifies the intersection of technology and medicine, showcasing his commitment to enhancing healthcare through innovation. His patents reflect a dedication to improving patient outcomes in hematology.